Type 2 & other diabetes

Trajectories of type 2 diabetes and cancer in 330 000 individuals with prediabetes: 20-year observational study in England

Lancet Diabetes EndocrinolPublished Population-based cohort study

Authors' conclusion

The trajectories of type 2 diabetes and cancer following a diagnosis of prediabetes varied substantially by age at prediabetes diagnosis and, to a lesser extent, other sociodemographic and lifestyle factors, with most younger individuals (aged <55 years) remaining in the prediabetes state. Strategies to improve the prevention and early identification of type 2 diabetes and cancer in individuals with prediabetes should be tailored to the age at which prediabetes is diagnosed.

Study context

Population
Individuals aged 18–100 years with newly diagnosed prediabetes, Jan 1, 1998–Nov 30, 2018, England (Clinical Practice Research Datalink)163,782 transitions
Participants
328,049 individuals
Outcome
Disease trajectories from prediabetes to T2D, cancer and death: state occupancy probabilities and sojourn times across eight states and seven transitions
Follow-up
10 years after prediabetes diagnosis
Methodological detailsmultistate model, linked primary care, hospital and mortality records
  • Multistate model
  • Linked primary care, hospital and mortality records

Main finding

As reported in the abstract

Probability of remaining in prediabetes state
23.2% (men aged ≥75 years) to 72.1% (men aged <55 years)
Probability of death following prediabetes
1.2% (women aged <55 years) to 38.7% (women aged ≥75 years)
Probability of developing T2D and remaining in this state
7.9% (men aged ≥75 years) to 24.0% (women aged <55 years)
Probability of developing cancer and remaining in this state
1.9% (men aged <55 years) to 7.8% (men aged ≥65 to <75 years)
Time spent in prediabetes state during 10 years
5.34 years (men aged ≥75 years) to 8.34 years (men aged <55 years)

Observational data: associations, not effects.

Further findings

Cancer incidence rates · over 10 years

Largest excess cancer incidence with T2D vs prediabetes, women
4.1 more cases per 1000 person-years
Largest excess cancer incidence with T2D vs prediabetes, men
4.8 more cases per 1000 person-years
Cancer incidence greater in older individuals (aged ≥75 years at prediabetes diagnosis), in women and men
  • Only marginally higher with T2D vs prediabetes

Associated factors

BMI, smoking, socioeconomic status and ethnicity were associated with occupancy probabilities and sojourn times

Original publication

Trajectories of type 2 diabetes and cancer in 330 000 individuals with prediabetes: 20-year observational study in England. Lancet Diabetes Endocrinol. Published 19 November 2025. doi:10.1016/s2213-8587(25)00285-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.